Citation Impact
Citing Papers
Riding the tiger – physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix
2020
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Idiopathic pulmonary fibrosis
2017 Standout
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events
2015
Mechanisms of Thrombus Formation
2008 Standout
Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
2016
Proton pump inhibitors in IPF: beyond mere suppression of gastric acidity
2016
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis
2014
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
Pulmonary Hypertension in Chronic Lung Diseases
2013
The changing landscape of atherosclerosis
2021 StandoutNature
The REDCap consortium: Building an international community of software platform partners
2019 Standout
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure
2016
Pulmonary hypertension in chronic lung disease and hypoxia
2018
Aspiration-Related Pulmonary Syndromes
2015
Advanced atherosclerosis imaging by CT: Radiomics, machine learning and deep learning
2019
Antithrombotic Therapy for VTE Disease
2012 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
2016
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale
2004
Executive Summary
2012 Standout
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
2016
Idiopathic pulmonary fibrosis
2017 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
2019 Standout
Sickle-cell disease
2010 Standout
Quantitative Chest CT Assessment of Small Airways Disease in Post-Acute SARS-CoV-2 Infection
2022
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Natural history of idiopathic pulmonary fibrosis
2015
Antithrombotic Therapy in Neonates and Children
2008
Antithrombotic Therapy in Neonates and Children
2012
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Restoring invisible and abandoned trials: a call for people to publish the findings
2013
Incidental pulmonary nodules in emergent coronary CT angiography for suspected acute coronary syndrome: Impact of revised 2017 Fleischner Society Guidelines
2017
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
2020
Anti‐factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis
2005
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Degree of Anticoagulation after One Subcutaneous and One Subsequent Intravenous Booster Dose of Enoxaparin: Implications for Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention
2004
Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events
2005
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
2015
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
2016
Epidemiology of idiopathic pulmonary fibrosis
2013
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS
2015
Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis
2016
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Is Mitochondrial Dysfunction a Common Root of Noncommunicable Chronic Diseases?
2020
Lung transplantation in IIP : A review
2015
Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review
2018
Leveraging Electronic Tablets and a Readily Available Data Capture Platform to Assess Chronic Pain in Children: The PROBE system
2015
Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings
2009
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Artificial Intelligence in Dentistry: Chances and Challenges
2020 Standout
Routine Screening of Coronary Artery Disease With Computed Tomographic Coronary Angiography in Place of Invasive Coronary Angiography in Patients Undergoing Transcatheter Aortic Valve Replacement
2015
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
2013
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Regulatory T Cells Limit Pneumococcus-Induced Exacerbation of Lung Fibrosis in Mice
2020
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Wound Healing: A Cellular Perspective
2018 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
Idiopathic Pulmonary Fibrosis
2018 Standout
Industry sponsorship and research outcome
2017 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of Eric Yow being referenced
Clinical Outcomes of Palliative Surgery Including a Systemic-to-Pulmonary Artery Shunt in Infants With Cyanotic Congenital Heart Disease
2007
Novel Mitochondria-Targeting Peptide in Heart Failure Treatment
2017
Abstract 2208: Optimal Dose of Clopidogrel for Platelet Inhibition in Children: Primary Results of the PICOLO Trial
2006
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials
2013
Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centre
2016
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention
2003
Pain, stiffness, and fatigue in juvenile polyarticular arthritis: Contemporaneous stressful events and mood as predictors
2005
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy
2012
Sildenafil Preserves Exercise Capacity in Patients With Idiopathic Pulmonary Fibrosis and Right-sided Ventricular Dysfunction
2013
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
2013
Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
2015
Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes
2016
Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children
2008